Display Settings:

Format

Send to:

Choose Destination
    J Alzheimers Dis. 2008 May;14(1):27-41.

    Identification of miRNA changes in Alzheimer's disease brain and CSF yields putative biomarkers and insights into disease pathways.

    Source

    Department of Pharmacogenetics, GlaxoSmithKline Inc., Research Triangle Park, NC 27709, USA. John.P.Cogswell@gsk.com

    Abstract

    MicroRNAs have essential functional roles in brain development and neuronal specification but their roles in neurodegenerative diseases such as Alzheimer's disease (AD) is unknown. Using a sensitive qRT-PCR platform we identified regional and stage-specific deregulation of miRNA expression in AD patient brains. We used experimental validation in addition to literature to reveal how the deregulated brain microRNAs are biomarkers for known and novel pathways in AD pathogenesis related to amyloid processing, neurogenesis, insulin resistance, and innate immunity. We additionally recovered miRNAs from cerebrospinal fluid and discovered AD-specific miRNA changes consistent with their role as potential biomarkers of disease.

    PMID:
    18525125
    [PubMed - indexed for MEDLINE]

      Supplemental Content

      Icon for IOS Press

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk